Abstract A new flavonoid, atalantraflavone (1) as well as eight known compounds including atalantoflavone (2), racemoflavone (3), 5,4′-dihydroxy-(3″,4″-dihydro-3″,4″-dihydroxy)-2″,2″-dimethylpyrano-(5″,6″:7,8)-flavone (4), lupalbigenin (5), anabellamide (6), citrusinine I (7), p-hydroxybenzaldehyde (8), and frideline (9), were isolated from the leaves of Atalantia monophylla (L.) DC. Focusing on Alzheimer’s disease, acetylcholine esterase (AChE) inhibition and antioxidant activity were evaluated using the modified Ellman’s method and the ABTS scavenging assay, respectively. It was found that isoflavonoid 5, lupalbigenin, showed 79% inhibition to AChE and was 1.4-fold stronger than the tacrine standard. In addition, acridone 7, citrusinine I, displayed 90.68% antioxidant activity.
A new flavonoid from the leaves of Atalantia monophylla (L.) DC
P. Posri,J. Suthiwong,Pitchayakarn Takomthong,Chatchawan Wongsa,Chindawadee Chuenban,Chantana Boonyarat,C. Yenjai
Published 2019 in Natural Product Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Natural Product Research
- Publication date
2019-04-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-21 of 21 references · Page 1 of 1
CITED BY
Showing 1-19 of 19 citing papers · Page 1 of 1